Hydrocortisone May Lower Severe CAP Mortality - Summary - MDSpire
From the Journals

Hydrocortisone May Lower Severe CAP Mortality

Network meta-analysis suggests hydrocortisone may offer mortality and ventilation benefits, although evidence certainty remained low.

  • By

  • Andrea Surnit

  • May 11, 2026

  • 3 min

Share

A network meta-analysis compared the efficacy of corticosteroids in reducing all-cause mortality in patients with severe community-acquired pneumonia (CAP). Among 2,042 patients from 11 randomized controlled trials, only hydrocortisone was linked to significantly lower mortality rates and a reduced need for mechanical ventilation. In contrast, dexamethasone, methylprednisolone, and prednisolone did not demonstrate similar benefits. The analysis flagged the importance of cautious interpretation due to its reliance on indirect comparisons and variability across studies. The findings suggest that while hydrocortisone shows promise, current treatment guidelines remain unchanged.

Original Source(s)

Hydrocortisone May Lower Severe CAP Mortality

  • by Andrea Surnit

  • May 11, 2026

Related Content

E-Cigarette Devices Linked to Inhaled Metal Exposure 

Device-to-tissue mass spectrometry traces metal emissions from e-cigarette components into exposed lung sections

  • May 12, 2026

  • 3 min
Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Folate Biomarkers Linked to Lung Cancer

Cross-sectional NHANES analysis found associations between select folate markers and self-reported physician-diagnosed lung cancer, though the direction and clinical significance of the relationship remain unclear